Mrv1902 03151916112D 17 18 0 0 1 0 999 V2000 0.2811 -0.8852 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 1.8460 0.5668 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.8966 -0.7990 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.6076 1.8768 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.1785 4.3520 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.1785 1.8768 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.8931 3.1144 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.1785 1.0518 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.5110 0.5668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7660 -0.2178 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 1.5910 -0.2178 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 2.0760 -0.8852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4640 2.2894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.8931 2.2894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4640 3.1144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1785 3.5270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2504 3.5270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10 1 1 1 0 0 0 2 8 1 0 0 0 0 2 11 1 0 0 0 0 3 12 1 0 0 0 0 4 14 2 0 0 0 0 5 16 2 0 0 0 0 8 6 1 6 0 0 0 6 13 1 0 0 0 0 6 14 1 0 0 0 0 7 14 1 0 0 0 0 7 16 1 0 0 0 0 8 9 1 0 0 0 0 9 10 1 0 0 0 0 10 11 1 0 0 0 0 11 12 1 6 0 0 0 13 15 2 0 0 0 0 15 16 1 0 0 0 0 15 17 1 0 0 0 0 M END > DB06198 > drugbank > CC1=CN([C@H]2C[C@H](F)[C@@H](CO)O2)C(=O)NC1=O > InChI=1S/C10H13FN2O4/c1-5-3-13(10(16)12-9(5)15)8-2-6(11)7(4-14)17-8/h3,6-8,14H,2,4H2,1H3,(H,12,15,16)/t6-,7+,8+/m0/s1 > UXCAQJAQSWSNPQ-XLPZGREQSA-N > C10H13FN2O4 > 244.222 > 244.08593507 > 4 > 30 > 22.485748416853795 > 1 > 2 > 0 > 1 > 1-[(2R,4S,5R)-4-fluoro-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione > -0.60 > -0.22796181533333285 > -0.49 > 0 > 2 > 0 > 14.578898179770059 > 10.110296959566844 > -2.983499511218235 > 78.87 > 53.719899999999996 > 2 > 1 > 7.92e+01 g/l > alovudine > 0 > DB06198 > investigational > Alovudine > Alovudine $$$$